In continuing efforts to elucidate the mechanism of pathogenesis of neoplasia using the N-nitroso tumor model, this proposal deals with modulation of the transformed state in anaplastic glioma cell line T9 established from one of the N-nitrosourea-induced tumors. Nerve growth factor (NGF) and glia maturation factor (GMF) have been found to induce changes of growth pattern as well as morphological differentiation of T9 cells in culture. This system will be utilized in this project to gain understanding of the mechanisms of NGF and GMF actions, which may provide the basis for the potential use of these physiological factors as reverse transforming agents in cancer therapy. The role of second messengers and their balance in reverse transformation will be studied by examining effects of bromo- cAMP, 1-oleoyl-2-acetylglycerol, 12-tetradecanoylphorbol-13- acetate, and Ca ionophore as well as effectors of second messenger production such as cholera toxin, forskolin and phosphatidic acid on growth differentiation of T9 cells. Expression of the cellular src gene and synthesis and phosphorylation of the src gene product as affected by NGF and GMF as well as various second messengers will be investigated in order to determine the relationship between reverse transformation of T9 cells and this gene product which is known to be closely associated with neural differentiation. Synthesis and phosphorylation of tubulin, intermediate filament proteins, actin and their associated proteins will be examined in T9 cells during exposure to NGF and GMF as well as various second messengers. Attempts will then be made to correlate changes in subcellular organization of cytoskeletons with NGF- and GMF-induced morphological differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032594-08
Application #
3170497
Study Section
Pathology A Study Section (PTHA)
Project Start
1981-01-01
Project End
1991-12-31
Budget Start
1990-01-01
Budget End
1991-12-31
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Michigan State University
Department
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Marushige, Y; Marushige, K; Koestner, A (1994) Growth inhibition of synchronized trigeminal neurinoma cells by nerve growth factor. Anticancer Res 14:153-6
Paul, D; Marushige, K (1994) Characterization of single-stranded DNA binding proteins in rat glial-enriched nuclei. Exp Mol Pathol 61:82-96
Marushige, Y; Marushige, K; Koestner, A (1992) Growth inhibition of anaplastic glioma cells by nerve growth factor. Anticancer Res 12:2069-73
Yaeger, M J; Koestner, A; Marushige, K et al. (1992) The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results. Acta Neuropathol 83:624-9
Yaeger, M J; Koestner, A; Marushige, K et al. (1991) The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results. Acta Neuropathol 83:72-80
Koestner, A (1990) Characterization of N-nitrosourea-induced tumors of the nervous system;their prospective value for studies of neurocarcinogenesis and brain tumor therapy. Toxicol Pathol 18:186-92
Raju, N R; Yaeger, M J; Okazaki, D L et al. (1990) Immunohistochemical characterization of rat central and peripheral nerve tumors induced by ethylnitrosourea. Toxicol Pathol 18:18-23
Marushige, Y; Marushige, K; Okazaki, D L et al. (1989) Cytoskeletal reorganization induced by nerve growth factor and glia maturation factor in anaplastic glioma cells. Anticancer Res 9:1143-8
Raju, N R; Koestner, A; Marushige, K et al. (1989) Effect of nerve growth factor on the transplacental induction of neurinomas by ethylnitrosourea in Sprague-Dawley rats. Cancer Res 49:7120-3
Marushige, Y; Marushige, K; Koestner, A (1989) Chemical control of growth and morphological characteristics of anaplastic glioma cells. Anticancer Res 9:1729-35

Showing the most recent 10 out of 14 publications